Please Wait.....
Report
Brazil Clinical Trials Market Report and Forecast 2025-2034
Market Report I 2025-06-20 I 250 Pages I EMR Inc.
The Brazil clinical trials market was valued at USD 1.51 Billion in 2024, driven by rising biotechnology investments and strengthened regulatory support with enhanced infrastructure initiatives in the region. The market is anticipated to grow at a CAGR of 4.90% during the forecast period of 2025-2034, with the values likely to reach USD 2.44 Billion by 2034. The increasing prevalence of conditions such as diabetes, cancer, and cardiovascular diseases is driving demand for new treatments and, in turn, clinical research.
Brazil Clinical Trials Market Overview
According to Regulatory Focus factsheet, Brazil registered around 10,000 clinical studies by April 2024. Clinical trials are essential for advancing medical knowledge and ensuring the approval of new therapies. The market is growing rapidly due to favorable government policies, increasing investments, and a large, diverse patient population. Brazil's expanding healthcare infrastructure, combined with a rising demand for clinical research activities, makes the country an attractive destination for conducting clinical trials.
Brazil Clinical Trials Market Growth Drivers
Rising Cancer Incidence to Accelerate the Market Growth
The increasing incidence of cancer is a major growth driver for the clinical trials market in Brazil. According to data published in July 2024, new cancer cases in Brazil rose significantly from approximately 489,000 in 2010 to about 704,000 in 2023. This sharp increase, especially in prostate cancer cases, is intensifying the need for innovative therapies, thereby supporting continued market growth in the forecast period.
Brazil Clinical Trials Market Trends
Some of the notable trends in the market include the advent of new regulations to support clinical trials in the region:
Ease in Clinical Trial Regulations to Boost Market Growth
The implementation of new legislation, aimed at strengthening participant protections and streamlining trial processes is a significant trend in the market. In June 2024, the Brazilian government, in collaboration with the Brazilian Health Regulatory Agency (ANVISA) changed its laws governing clinical trials. Signed in May 2024 and effective from August, the law consolidated existing regulations, introduced a national ethics system, and decentralized ethical oversight. By accelerating protocol reviews and ensuring post-trial access to medicines, such alterations are expected to boost clinical research efficiency and market growth in the coming years.
Brazil Clinical Trials Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Market Breakup by Service Type
- Laboratory Services
- Bioanalytical Testing Services
??- Cell-Based Assay
??- Virology Testing
??- Serology, Immunogenicity, & Neutralizing Antibodies
??- PK/PD Testing
??- Method Development, Optimization & Validation
??- Biomarker Testing
??- Other Bioanalytical Testing Services
- Decentralized Clinical Trial Services
- Patient Recruitment
- Site Identification
- Analytical Testing Services
- Clinical Trial Supply & Logistic Services
- Protocol Designing
- Clinical Trial Data Management Services
- Medical Device Testing Services
- Other Service
Market Breakup by Therapeutic Areas
- Oncology
- Infectious Diseases
- Neurology
- Metabolic Disorders
- Immunology
- Cardiology
- Genetic Diseases
- Women's Health
- Other Therapeutic Areas
Market Breakup by Type of Pharmaceutical Product
- Small Molecules
- Monoclonal Antibodies
- Vaccine
- Cell & Gene Therapy
- Other Applications
Market Breakup by Study Design
- Interventional
- Observational
Market Breakup by Delivery Model
- Full-Service Outsourcing (FSO) Model
- Functional Service Provider (FSP) Model
- Hybrid Model
Market Breakup by End User
- Pharmaceutical & Biopharmaceutical Companies
- Medical Devices Companies
- Academic Institutes
- Other
Brazil Clinical Trials Market Share
Patient Recruitment Services Type Segmentation to Lead the Brazil Clinical Trials Market
The market is divided into a variety of service types, including laboratory services, bioanalytical testing services, patient recruitment, decentralized clinical trials, clinical trial supply and logistics, and more. Among these, patient recruitment services are expected to dominate. The effectiveness of a clinical trial often depends on the speed and accuracy of patient recruitment, which is essential for timely trial completion and accurate results. As the demand for clinical trials across therapeutic areas continues to grow, efficient patient recruitment will be a significant driver of market success in Brazil.
Oncology to Witness Substantial Growth in the Market Segmentation by Therapeutic Areas
There is an emphasis clinical trials on several therapeutic areas, including oncology, infectious diseases, neurology, cardiology, and metabolic disorders, among others. According to projections by the Brazilian National Cancer Institute (INCA), Brazil is expected to record over 704,000 new cancer cases each year between 2023 and 2025, excluding non-melanoma skin cancers. As a result, oncology is projected to be the leading therapeutic area due to the increasing prevalence of cancer in Brazil and worldwide. With rising investments in cancer research and the growing demand for new treatment options, clinical trials in oncology are expected to dominate. These trials are pivotal for the development of cutting-edge cancer therapies, making oncology a focal point of clinical research in the Brazilian market.
Leading Players in the Brazil Clinical Trials Market
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Cohortias
Cohortias, established as a full-service Contract Research Organization (CRO) that specializes in clinical trials across Latin America. Established to meet the growing demand for clinical research, Cohortias offers services like early-phase studies, rescue studies, and phase II and III trials, along with medical device trials. They are renowned for their expansive network, with over 250 sites and 10,500 conducted studies. Cohortias focuses on therapeutic areas including oncology, cardiology, and infectious diseases, playing a pivotal role in advancing clinical research in Brazil and the wider Latin American region.
Parexel Brazil
Parexel operates across multiple regions, including Brazil, where it supports clinical trial services. The company offers end-to-end clinical development services. Parexel specializes in phases I-IV trials, helping accelerate drug development globally. Their involvement in Brazil's clinical trials market is vital due to its vast patient population and the company's deep expertise in clinical, regulatory, and market access solutions, supporting a wide range of trials, including rare diseases and vaccines.
PPD (Thermo Fisher Scientific Inc.)
PPD, a Thermo Fisher Scientific company, focuses on early-phase clinical trials, particularly Phase I and Ib studies, assessing the clinical relevance and commercial viability of compounds. Their services include patient recruitment, investigator engagement, and trial design, ensuring the success of subsequent trials. PPD's expertise in early clinical development leverages extensive global resources, making them a significant player in the clinical trials market, supporting both patient safety and regulatory submission processes.
ICON plc
ICON plc is a prominent global Contract Research Organization (CRO). It was established in 1990 and is headquartered in Dublin, Ireland. With a significant presence in Latin America, including Brazil, ICON conducts clinical trials across various therapeutic areas, including cardiovascular, cancer, and infectious diseases. ICON's expertise in local regulations, patient enrollment, and cultural understanding allows it to effectively manage complex clinical trials. The company's commitment to high-quality research and patient retention has solidified its leadership in Brazil's growing clinical trials market, making it a trusted partner for global and regional study delivery.
Other key players in the market include Fractals Clinical Research, IQVIA Inc., Medpace, ACTIVA-CRO, and Centre International de Developpement Pharmaceutique Ltee (CIDP).
Key Questions Answered in the Brazil Clinical Trials Market Report
- What was the Brazil clinical trials market value in 2024?
- What is the Brazil clinical trials market forecast outlook for 2025-2034?
- What are the major factors aiding the Brazil clinical trials market demand?
- How has the market performed so far, and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- What is the major Brazil clinical trials market trends?
- Which phase is expected to dominate the market segment?
- Which service type is projected to lead the market segment?
- Which therapeutic area is anticipated to drive the market segment?
- Which application is likely to dominate the market segment?
- Who are the key players involved in the Brazil clinical trials market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Clinical Trials Market Overview
3.1 Latin America Clinical Trials Market
3.1.1 Latin America Clinical Trials Market Historical Value (2018-2024)
3.1.2 Latin America Clinical Trials Market Forecast Value (2025-2034)
3.2 Brazil Clinical Trials Market
3.2.1 Brazil Clinical Trials Market Historical Value (2018-2024)
3.2.2 Brazil Clinical Trials Market Forecast Value (2025-2034)
4 Brazil Clinical Trials Market Landscape
4.1 Brazil Clinical Trials Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Brazil Clinical Trials Market: Service Landscape
4.2.1 Analysis By Phase
4.2.2 Analysis By Service Type
4.2.3 Analysis By Application
4.2.4 Analysis By Type of Pharmaceutical Product
5 Brazil Clinical Trials Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 PESTEL Analysis
5.3.1 Political
5.3.2 Economic
5.3.3 Social
5.3.4 Technological
5.3.5 Legal
5.3.6 Environment
5.4 Porter's Five Forces Model
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Buyers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitutes
5.4.5 Degree of Rivalry
5.5 Key Demand Indicators
5.6 Key Price Indicators
5.7 Industry Events, Initiatives, and Trends
5.8 Value Chain Analysis
6 Brazil Clinical Trials Market Segmentation (218-2034)
6.1 Brazil Clinical Trials Market (2018-2034) by Phase
6.1.1 Market Overview
6.1.2 Phase I
6.1.3 Phase II
6.1.4 Phase III
6.1.5 Phase IV
6.2 Brazil Clinical Trials Market (2018-2034) by Service Type
6.2.1 Market Overview
6.2.2 Laboratory Services
6.2.3 Bioanalytical Testing Services
6.2.3.1 Cell-Based Assay
6.2.3.2 Virology Testing
6.2.3.3 Serology, Immunogenicity, & Neutralizing Antibodies
6.2.3.4 PK/PD Testing
6.2.3.5 Method Development, Optimization & Validation
6.2.3.6 Biomarker Testing
6.2.3.7 Other Bioanalytical Testing Services
6.2.4 Decentralized Clinical Trial Services
6.2.5 Patient Recruitment
6.2.6 Site Identification
6.2.7 Analytical Testing Services
6.2.8 Clinical Trial Supply & Logistic Services
6.2.9 Protocol Designing
6.2.10 Clinical Trial Data Management Services
6.2.11 Medical Device Testing Services
6.2.12 Other Service
6.3 Brazil Clinical Trials Market (2018-2034) by Therapeutic Areas
6.3.1 Market Overview
6.3.2 Oncology
6.3.3 Infectious Diseases
6.3.4 Neurology
6.3.5 Metabolic Disorders
6.3.6 Immunology
6.3.7 Cardiology
6.3.8 Genetic Diseases
6.3.9 Women's Health
6.3.10 Other Therapeutic Areas
6.4 Brazil Clinical Trials Market (2018-2034) by Type of Pharmaceutical Product
6.4.1 Market Overview
6.4.2 Small Molecules
6.4.3 Monoclonal Antibodies
6.4.4 Vaccine
6.4.5 Cell & Gene Therapy
6.4.6 Others
6.5 Brazil Clinical Trials Market (2018-2034) by Study Design
6.5.1 Market Overview
6.5.2 Interventional
6.5.3 Observational
6.6 Brazil Clinical Trials Market (2018-2034) by Delivery Model
6.6.1 Market Overview
6.6.2 Full-Service Outsourcing (FSO) Model
6.6.3 Functional Service Provider (FSP) Model
6.6.4 Hybrid Model
6.7 Brazil Clinical Trials Market (2018-2034) by End User
6.7.1 Market Overview
6.7.2 Pharmaceutical & Biopharmaceutical Companies
6.7.3 Medical Devices Companies
6.7.4 Academic Institutes
6.7.5 Other
7 Regulatory Framework
8 Funding and Investment Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
9 Strategic Initiatives
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Initiatives
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Supplier Landscape
10.1 Market Share Analysis, By Country (Top 5 Companies)
10.2 Cohortias
10.2.1 Financial Analysis
10.2.2 Product Portfolio
10.2.3 Demographic Reach and Achievements
10.2.4 Company News and Developments
10.2.5 Certifications
10.3 Fractals Clinical Research
10.3.1 Financial Analysis
10.3.2 Product Portfolio
10.3.3 Demographic Reach and Achievements
10.3.4 Company News and Developments
10.3.5 Certifications
10.4 IQVIA Inc.
10.4.1 Financial Analysis
10.4.2 Product Portfolio
10.4.3 Demographic Reach and Achievements
10.4.4 Company News and Developments
10.4.5 Certifications
10.5 PPD (Thermo Fisher Scientific Inc.)
10.5.1 Financial Analysis
10.5.2 Product Portfolio
10.5.3 Demographic Reach and Achievements
10.5.4 Company News and Developments
10.5.5 Certifications
10.6 Medpace
10.6.1 Financial Analysis
10.6.2 Product Portfolio
10.6.3 Demographic Reach and Achievements
10.6.4 Company News and Developments
10.6.5 Certifications
10.7 ICON plc
10.7.1 Financial Analysis
10.7.2 Product Portfolio
10.7.3 Demographic Reach and Achievements
10.7.4 Company News and Developments
10.7.5 Certifications
10.8 ACTIVA-CRO
10.8.1 Financial Analysis
10.8.2 Product Portfolio
10.8.3 Demographic Reach and Achievements
10.8.4 Company News and Developments
10.8.5 Certifications
10.9 Centre International de Developpement Pharmaceutique Ltee (CIDP)
10.9.1 Financial Analysis
10.9.2 Product Portfolio
10.9.3 Demographic Reach and Achievements
10.9.4 Company News and Developments
10.9.5 Certifications
11 Brazil Clinical Trials Market - Distribution Model (Additional Insight)
11.1 Overview
11.2 Potential Distributors
11.3 Key Parameters for Distribution Partner Assessment
12 Key Opinion Leaders (KOL) Insights (Additional Insight)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security